| Drug General Information |
| Drug ID |
D0Y6DJ
|
| Drug Name |
rawsonol
|
| Synonyms |
125111-69-5; rawsonol
|
| Drug Type |
Small molecular drug
|
| Indication |
Unspecified
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C29H24Br4O7
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
3-hydroxy-3-methylglutaryl-coenzyme A reductase |
Target Info |
Modulator |
|
|---|
|
BioCyc Pathway
|
Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)
|
|
Superpathway of cholesterol biosynthesis
|
|
Mevalonate pathway
|
|
KEGG Pathway
|
Terpenoid backbone biosynthesis
|
|
Metabolic pathways
|
|
Biosynthesis of antibiotics
|
|
AMPK signaling pathway
|
|
Bile secretion
|
|
NetPath Pathway
|
IL5 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
TSH Signaling Pathway
|
|
PANTHER Pathway
|
Cholesterol biosynthesis
|
|
PathWhiz Pathway
|
Steroid Biosynthesis
|
|
WikiPathways
|
Statin Pathway
|
|
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
Activation of Gene Expression by SREBP (SREBF)
|
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
|
Integrated Breast Cancer Pathway
|
|
SREBP signalling
|
|
Cholesterol Biosynthesis
|
| References |
| REF 1 | Bromophenols in Marine Algae and Their Bioactivities |
|---|
